Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects

Non-steroidal anti-inflammatory drugs (NSAIDs) express anti-tumoral activity mainly by blocking cyclooxygenase-2 involved in the synthesis of prostaglandins. Therefore, in the last few decades, many have attempted to explore the possibilities of applying this group of drugs as effective agents for t...

Full description

Bibliographic Details
Main Authors: Vaikunthavasan Thiruchenthooran, Elena Sánchez-López, Anna Gliszczyńska
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/2/475
_version_ 1797444803660611584
author Vaikunthavasan Thiruchenthooran
Elena Sánchez-López
Anna Gliszczyńska
author_facet Vaikunthavasan Thiruchenthooran
Elena Sánchez-López
Anna Gliszczyńska
author_sort Vaikunthavasan Thiruchenthooran
collection DOAJ
description Non-steroidal anti-inflammatory drugs (NSAIDs) express anti-tumoral activity mainly by blocking cyclooxygenase-2 involved in the synthesis of prostaglandins. Therefore, in the last few decades, many have attempted to explore the possibilities of applying this group of drugs as effective agents for the inhibition of neoplastic processes. This review summarizes the evidence presented in the literature regarding the anti-tumoral actions of NSAIDs used as monotherapies as well as in combination with conventional chemotherapeutics and natural products. In several clinical trials, it was proven that combinations of NSAIDs and chemotherapeutic drugs (CTDs) were able to obtain suitable results. The combination with phospholipids may resolve the adverse effects of NSAIDs and deliver derivatives with increased antitumor activity, whereas hybrids with terpenoids exhibit superior activity against their parent drugs or physical mixtures. Therefore, the application of NSAIDs in cancer therapy seems to be still an open chapter and requires deep and careful evaluation. The literature’s data indicate the possibilities of re-purposing anti-inflammatory drugs currently approved for cancer treatments.
first_indexed 2024-03-09T13:17:49Z
format Article
id doaj.art-c6d5284734a04983ac6cf800bbff0fe5
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T13:17:49Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-c6d5284734a04983ac6cf800bbff0fe52023-11-30T21:34:24ZengMDPI AGCancers2072-66942023-01-0115247510.3390/cancers15020475Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side EffectsVaikunthavasan Thiruchenthooran0Elena Sánchez-López1Anna Gliszczyńska2Department of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, PolandDepartment of Pharmacy, Pharmaceutical Technology and Physical Chemistry, University of Barcelona, 08028 Barcelona, SpainDepartment of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, PolandNon-steroidal anti-inflammatory drugs (NSAIDs) express anti-tumoral activity mainly by blocking cyclooxygenase-2 involved in the synthesis of prostaglandins. Therefore, in the last few decades, many have attempted to explore the possibilities of applying this group of drugs as effective agents for the inhibition of neoplastic processes. This review summarizes the evidence presented in the literature regarding the anti-tumoral actions of NSAIDs used as monotherapies as well as in combination with conventional chemotherapeutics and natural products. In several clinical trials, it was proven that combinations of NSAIDs and chemotherapeutic drugs (CTDs) were able to obtain suitable results. The combination with phospholipids may resolve the adverse effects of NSAIDs and deliver derivatives with increased antitumor activity, whereas hybrids with terpenoids exhibit superior activity against their parent drugs or physical mixtures. Therefore, the application of NSAIDs in cancer therapy seems to be still an open chapter and requires deep and careful evaluation. The literature’s data indicate the possibilities of re-purposing anti-inflammatory drugs currently approved for cancer treatments.https://www.mdpi.com/2072-6694/15/2/475NSAIDschemotherapeutic drugsphosphatidylcholineterpenoidsanti-cancer therapy
spellingShingle Vaikunthavasan Thiruchenthooran
Elena Sánchez-López
Anna Gliszczyńska
Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects
Cancers
NSAIDs
chemotherapeutic drugs
phosphatidylcholine
terpenoids
anti-cancer therapy
title Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects
title_full Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects
title_fullStr Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects
title_full_unstemmed Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects
title_short Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects
title_sort perspectives of the application of non steroidal anti inflammatory drugs in cancer therapy attempts to overcome their unfavorable side effects
topic NSAIDs
chemotherapeutic drugs
phosphatidylcholine
terpenoids
anti-cancer therapy
url https://www.mdpi.com/2072-6694/15/2/475
work_keys_str_mv AT vaikunthavasanthiruchenthooran perspectivesoftheapplicationofnonsteroidalantiinflammatorydrugsincancertherapyattemptstoovercometheirunfavorablesideeffects
AT elenasanchezlopez perspectivesoftheapplicationofnonsteroidalantiinflammatorydrugsincancertherapyattemptstoovercometheirunfavorablesideeffects
AT annagliszczynska perspectivesoftheapplicationofnonsteroidalantiinflammatorydrugsincancertherapyattemptstoovercometheirunfavorablesideeffects